Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®)

<table class="figure-group"><tr class="fig-image" id="a"><td><object data="https://static.hindawi.com/articles/jir/volume-2019/2754920/figures/2754920.fig.002a.svgz" name="2754920.fig.002a" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(a) </b>Capture/sandwich ELISA</td></tr><tr class="fig-image" id="b"><td><object data="https://static.hindawi.com/articles/jir/volume-2019/2754920/figures/2754920.fig.002b.svgz" name="2754920.fig.002b" type="image/svg+xml"></object></td></tr><tr class="fig-caption"><td><b>(b) </b>Competition/inhibition ELISA</td></tr></table>

<div>ELISA techniques. Capture/sandwich ELISA and competition/inhibition ELISA. Different antibodies used, in blue: rabbit IgG anti-TCRP-KLH; in red: mice sera pool anti-TCRP-KLH; in grey: HRP-labeled anti-mouse IgG.</div>

Journal of Immunology Research

fig2

Figure 2

Figure 2: Development of Functional Antibodies Directed to Human Dialyzable Leukocyte Extract (Transferon®) 